ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382049; 2) Community: the network communities that were significantly associated with the response to NSC 382049; 3) Molecule: the relationships between components within communities and NSC 382049; 4) MDR: the compounds that were significantly associated with the NSC 382049.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.0102077332082017 0.51806391
NSC 94945 Questiomycin A 0.0102077332082017 0.23634695
NSC 39789 Null 0.0102962192514438 0.1991865
NSC 623527 Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt 0.0102962192514438 0.29312252
NSC 632831 Null 0.0102962192514438 0.34294518
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.0102962192514438 0.0041947056
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0102962192514438 0.3112471
NSC 653625 Null 0.0102962192514438 0.27001766
NSC 669973 Null 0.0102962192514438 0.47137964
NSC 675988 11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- 0.0102962192514438 0.53730038
Total:136  Current:38    [First] [Prev] [Next] [Last]